Follow Us
  • Facebook Basic Black
  • Twitter Basic Black
  • LinkedIn Social Icon

"Finerenone cuts albuminuria in diabetic nephropathy"

"Adding the mineralocorticoid receptor antagonist finerenone to standard renin-angiotensin system (RAS) blockade decreased albuminuria and improved the urinary albumin/creatinine ratio in an industry-sponsored phase IIB clinical trial of diabetic nephropathy, according to a report published online Sept. 1 in JAMA."

Click here to read the full article


#news #Type2diabetes #hottopics #nephropathy

Must Read

Awards & Honors

All Contents © Copyright Epinex Diagnostics, Inc. 2011. All Rights Reserved